[Double-blind clinical evaluation of choleretic agents in patients with chronic liver disease and cholestasis syndromes].
D002164:Camphor / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D002779:Cholestasis / Q000188:drug therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003685:Dehydrocholic Acid / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D002756:Cholagogues and Choleretics; D002164:Camphor; D003685:Dehydrocholic Acid; C029077:camphoric acid 1-methyl ester
Valutazione clinica in doppio cieco di farmaci coleretici in pazienti affetti da epatopatie croniche e da sindromi colostatiche.